[Latest] Global Pulmonary Arterial Hypertension (PAH) Market Size/Share Worth USD 326.9 Million by 2030 at an 5.20% CAGR: Markets N Research (Size, Report, Access, Growth, Trends, Dynamics, Value)
March 13, 2023 12:00 ET
|
Markets N Research
Chicago, March 13, 2023 (GLOBE NEWSWIRE) -- Markets N Research has recently released expansive research on Global Pulmonary Arterial Hypertension (PAH) Market with 220+ market data Tables, Pie...
The First PHantasticals Come to Life to Raise Awareness of Pulmonary Hypertension
May 05, 2022 05:00 ET
|
Ferrer
BARCELONA, Spain, May 05, 2022 (GLOBE NEWSWIRE) -- Coinciding with World Pulmonary Hypertension (PH) Day, which is celebrated every May 5, Ferrer and the European Pulmonary Hypertension Association...
Liquidia Technologies Reports Positive Interim LIQ861 Safety Data on 109 Patients from Pivotal INSPIRE Trial
January 07, 2019 07:00 ET
|
Liquidia Technologies, Inc.
LIQ861 was well-tolerated in PAH patients at two-weeks of treatment, the safety endpoint requested by U.S. FDANDA submission targeted for late 2019 RESEARCH TRIANGLE PARK, N.C., Jan. 07, 2019 ...
Pulmonary Arterial Hypertension Treatment Market to Attain a Value of US$ 6.5 Billion by 2028– Future Market Insights
September 05, 2018 10:00 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
VALLEY COTTAGE, N.Y. , Sept. 05, 2018 (GLOBE NEWSWIRE) -- Owing to non-responsive nature of several advance pharmacotherapies and high diagnosis and treatment costs, researchers and medical...